Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

iZumi Bio and Pierian merge to form iPierian

Executive Summary

Stem cell companies iZumi Bio and Pierian (formed by faculty at Harvard University) have merged to form iPierian, an entity that will focus on using induced pluripotent stem (iPS) cells as therapies for diseases that are hard to treat.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies